Flobak Å, Skånland SS, Hovig E, Taskén K, Russnes HG(2022) Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models Trends Pharmacol Sci, 43(11), 973-985 DOI 10.1016/j.tips.2022.08.009, PubMed 36163057
Ree AH, Mælandsmo GM, Flatmark K, Russnes HG, Gómez Castañeda M, Aas E(2022) Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer - the MetAction precision medicine study Acta Oncol, 61(8), 955-962 DOI 10.1080/0284186X.2022.2098053, PubMed 35943168
Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich Det al.(2022) Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway J Transl Med, 20(1), 317 DOI 10.1186/s12967-022-03518-0, PubMed 35841045
